Renal Cancer - Results from #6360

First-line and sequential use of pazopanib followed by mammalian target of rapamycin inhibitor therapy among patients with advanced renal cell carcinoma in a US community oncology setting - Abstract April 7, 2015

Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: A systematic review and meta-analysis of real-world observational studies - Abstract April 7, 2015

Survival after renal cell carcinoma metastasis to the thyroid: Single center experience and systematic review of the literature - Abstract April 7, 2015

De novo renal cell carcinoma in an allograft kidney treated with nephron-sparing surgery: A case report - Abstract April 3, 2015

Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment survey - Abstract April 3, 2015

Prognostic factors for overall survival with targeted therapy in Chinese patients with metastatic renal cell carcinoma - Abstract April 3, 2015

How I do it: Laparoscopic renal cryoablation (LRC) - Abstract April 3, 2015

Zero ischaemia laparoscopic nephron-sparing surgery by re-suturing - Abstract April 3, 2015

Quantitative tumour necrosis is an independent predictor of overall survival in clear cell renal cell carcinoma - Abstract April 2, 2015

Local recurrence in the neck and survival after thyroidectomy for metastatic renal cell carcinoma - Abstract April 1, 2015

Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitor - Abstract April 1, 2015

Multiparametric MRI of solid renal masses: Pearls and pitfalls - Abstract April 1, 2015

Efficacy and tolerability of a low-dose, 2-week administration of sunitinib followed by a week rest (2/1 schedule) for metastatic renal cell carcinoma: A single center experience of six cases - Abstract March 31, 2015

Clinical characteristics and prognosis of patients with renal cell carcinoma and liver metastasis - Abstract March 31, 2015

Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma - Abstract March 31, 2015

Evidence and clinical relevance of tumor flare in patients who discontinue tyrosine kinase inhibitors for treatment of metastatic renal cell carcinoma - Abstract March 30, 2015

Increased risk of everolimus-associated acute kidney injury in cancer patients with impaired kidney function - Abstract March 30, 2015

Everolimus in patients with metastatic renal cell carcinoma previously treated with bevacizumab: A prospective multicenter study CRAD001LRU02T - Abstract March 30, 2015

Phase I trial of sunitinib and temsirolimus in metastatic renal cell carcinoma - Abstract March 27, 2015

Interdisciplinary counseling service for renal malignancies: A patient-centered approach to raise guideline adherence - Abstract March 27, 2015

Page 319 of 458